Article

Cardioprotective Effects of Piperlongumine against Doxorubicin-Induced Myocardial Infarction via Down-Regulating Cardiac Biomarkers in Rats

Guo Xiong1★★ Corresponding author

  1. 1Department of Cardiovascular Medicine, The Third People's Hospital of Yibin, Sichuan Province, CHINA.

CORRESPONDENCE

Guo Xiong

Department of Cardiovascular Medicine, The Third People's Hospital of Yibin, Sichuan Province, CHINA.

guoxiong0709@sina.com

Received: 11-09-2025; Revised: 28-10-2025; Accepted: 08-12-2025.

Volume 60, Issue 2 · pp. 758–767 · PUBLISHED · DOI: 10.5530/ijper.20262259

View on IJPER original site ↗

ABSTRACT

Background:Doxorubicin, an extensively utilized antineoplastic agent, has been a significant contributor to the remarkable advancements in cancer treatment over the past several decades. However, the clinical usefulness of this powerful drug is often restricted by its well-documented cardiotoxic effects.Objectives:The present research work was focused at unveiling the therapeutic roles of piperlongumine against doxorubicin-induced cardiotoxicity. Materials and Methods: The experimental rats were received 2.5 mg/kg of doxorubicin to induce cardiotoxicity, subsequently treated with 50 mg/kg of piperlongumine. Plethysmography via the tail-cuff was employed to assess hemodynamic parameters. The oxidative and antioxidative biomarkers, and cardiac function markers, were quantified using a commercial assay kits. The concentrations of inflammatory biomarkers and apoptotic proteins were also assessed using the kits. Results: The piperlongumine treatment considerably enhanced the heart and body weights of the doxorubicin-induced rats. The piperlongumine treatment significantly lowered the hemodynamic parameters in rats with doxorubicin-induced cardiotoxicity. Furthermore, the piperlongumine treatment markedly reduced the activities of cardiac function markers and inflammatory biomarkers in the doxorubicin-induced rats.Conclusion: The present findings exhibited that piperlongumine can mitigate the biochemical and cardiotoxic effects induced by doxorubicin in rats via its robust antioxidant and anti-inflammatory effects. Thus, piperlongumine may serve as an novel treatment option in conjunction with doxorubicin to mitigate its cardiotoxic effects.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Xiong, G. (). Cardioprotective Effects of Piperlongumine against Doxorubicin-Induced Myocardial Infarction via Down-Regulating Cardiac Biomarkers in Rats. Indian Journal of Pharmaceutical Education and Research, 60(2), 758–767. https://doi.org/10.5530/ijper.20262259